Predicting Bone Cement Implantation Syndrome Using Artificial Intelligence Methods
ConditionBone Cement Implantation Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAtaturk University
About this trial
This study aims to predict the development of bone cement syndrome, which may develop due to polymethylmethacrylate cement used to adhere the prosthesis to the bone in arthroplasty surgeries, which may cause intraoperative and postoperative mortality and morbidity, using artificial intelligence methods and to provide a sustainable life comfort to patients in the postoperative period with the standardization predicted in the long term.
Eligibility criteria
Qualifiers
Total knee arthrplasties
Partial hip arthrplasty using cement
Total hip arthrplasty using cement
Patients ≥18 years old.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Collecting data from patients who underwent arthroplasty and cement was used
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov